相关实验视频
Updated: May 22, 2026

06:53
Selective Harvesting of Marginating-hepatic Leukocytes
Published on: July 21, 2016
5.7K
在已故捐赠者中评估肝脏NK细胞质量的预测因素
Yuki Imaoka1,2, Masahiro Ohira1,3, Toshihiro Nakayama2
1Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Cell transplantation
|February 5, 2025
概括
来自已故捐赠者的肝脏自然杀手 (NK) 细胞显示出可变的抗瘤活性. 捐赠者的特征,如白细胞计数和AST水平,可以预测NK细胞的免疫疗法潜力的质量.
科学领域:
- 免疫学 免疫学 免疫学
- 移植生物学 移植生物学
- 细胞疗法细胞疗法
背景情况:
- 从已故捐赠者 (DD) 获得的肝脏自然杀手 (NK) 细胞的免疫质量存在显著的变化.
- 了解影响NK细胞功能的因素对于优化它们在免疫疗法中的使用至关重要.
研究的目的:
- 调查来自DDs的肝脏NK细胞质量的变异性.
- 识别与增强NK细胞激活和细胞毒性相关的供体特征.
- 开发一个预测模型来识别高质量的肝 NK 细胞,用于治疗应用.
主要方法:
- 评估了来自51个DDs的肝脏非基细胞.
- 测量了激活受体的表达,包括与TNF相关的诱导亡的配体 (TRAIL) 和NK组2成员D (NKG2D).
- 对K562 (白血病) 和HepG2 (肝瘤) 细胞系进行评估的NK细胞细胞毒性.
- 与NK细胞标志物和功能相关的捐赠者参数 (白细胞计数,AST,BMI,血小板计数).
主要成果:
- 在来自DDs的肝 NK 细胞中观察到 TRAIL 和 NKG2D 表达和细胞毒性的实质性变异.
- 较高的白细胞 (WBC) 计数,阿斯巴酸胺转移酶 (AST) 水平,体重指数 (BMI) 和较低的血小板计数与增加的 TRAIL 和 NKG2D 表达有关.
- 开发了一个整合AST/血小板比率指数,BMI和WBC计数的预测得分.
结论:
- 捐赠者的特征显著影响了来自DDs的肝NK细胞的质量和抗瘤潜力.
- 开发的预测得分可以识别具有适合免疫治疗的高质量的肝 NK 细胞的 DD.
- 这一发现有助于为基于NK细胞的癌症疗法选择最佳的供体材料.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

